Mt-I
Mt-I · [Nle⁴,D-Phe⁷]-α-MSH
A linear α-MSH analog studied for melanogenesis and photoprotection pathways in research.
Mass
- 10 mg$32.99In stock
From $32.99Purity 99.74%Third-party tested— View COA
Related
More to explore
Specifications
| CAS number | 75921-69-6 |
|---|---|
| Molecular formula | C78H111N21O19 |
| Molecular weight | 1646.9 g/mol |
| Form | Lyophilized powder |
| Purity (latest released COA) | 99.74% · AST-MT1-001 |
| Net quantity | 10 mg / vial |
Handling & storage
| Guidance | Store lyophilized powder at −20 °C, protected from light. After reconstitution with bacteriostatic water, store at 2–8 °C and use within 30 days. Every vial ships with a batch-specific Certificate of Analysis. |
|---|
For laboratory research use only. Not a drug, food, cosmetic or supplement. Not for human or veterinary consumption, diagnosis, or treatment.
Documentation
Certificates of Analysis
Batch-specific, third-party lab certificates. Each COA is published here once its lot has been tested — preview the results, then open the full PDF.
Current released record
AST-MT1-001
- Dosage
- 10 mg
- Purity
- 99.74%
- Laboratory
- ILS Laboratories
- Analyzed
- 2026-08-06
Related peer-reviewed research
- Afamelanotide clinical-lineage researchAfamelanotide, an agonistic analog of α-melanocyte-stimulating hormone, in dermal phototoxicity of erythropoietic protoporphyria. Expert Opinion on Investigational Drugs (2010)
- Afamelanotide clinical-lineage researchAfamelanotide for Erythropoietic Protoporphyria. New England Journal of Medicine (2015)